Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
D 79.08 -0.23% -0.18
CDNA closed down 0.23 percent on Friday, February 26, 2021, on 1.35 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CDNA trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Lower Bollinger Band Touch Weakness 0.00%
50 DMA Resistance Bearish -0.23%
MACD Bearish Centerline Cross Bearish -0.23%
Pocket Pivot Bullish Swing Setup -0.23%
Multiple of Ten Bearish Other -0.23%
50 DMA Resistance Bearish 0.06%
Multiple of Ten Bearish Other 0.06%
Fell Below 50 DMA Bearish 2.50%
Older End-of-Day Signals for CDNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


CareDx, Inc. Description

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine In Vitro Gene Expression Blood Test Transplantation Medicine Organ Transplantation Transplant Rejection

Is CDNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 99.83
52 Week Low 13.04
Average Volume 771,445
200-Day Moving Average 50.64
50-Day Moving Average 80.87
20-Day Moving Average 84.85
10-Day Moving Average 82.52
Average True Range 5.72
ADX 21.8
+DI 17.50
-DI 30.91
Chandelier Exit (Long, 3 ATRs ) 77.50
Chandelier Exit (Short, 3 ATRs ) 86.27
Upper Bollinger Band 95.01
Lower Bollinger Band 74.68
Percent B (%b) 0.22
BandWidth 23.97
MACD Line -0.51
MACD Signal Line 0.99
MACD Histogram -1.4989
Fundamentals Value
Market Cap 3.9 Billion
Num Shares 49.3 Million
EPS -0.97
Price-to-Earnings (P/E) Ratio -81.44
Price-to-Sales 15.59
Price-to-Book 10.82
PEG Ratio -0.12
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.04
Resistance 3 (R3) 90.71 86.40 89.04
Resistance 2 (R2) 86.40 83.36 86.56 88.38
Resistance 1 (R1) 82.74 81.47 80.59 83.07 87.71
Pivot Point 78.43 78.43 77.35 78.59 78.43
Support 1 (S1) 74.77 75.39 72.62 75.10 70.45
Support 2 (S2) 70.46 73.50 70.62 69.78
Support 3 (S3) 66.80 70.46 69.12
Support 4 (S4) 67.13